此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

测试研究药物 Zanubrutinib 对先前未经治疗的套细胞淋巴瘤老年患者的连续治疗与间歇治疗

2026年11月2日 更新者:Alliance for Clinical Trials in Oncology

使用 Zanubrutinib 作为老年套细胞淋巴瘤患者前期治疗的连续与间歇维持治疗的随机 3 期试验

This phase III trial tests whether continuous or intermittent zanubrutinib after achieving a complete remission (CR) with rituximab works in older adult patients with mantle cell lymphoma (MCL) who have not received treatment in the past (previously untreated). Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Zanubrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. When zanubrutinib is used in MCL, the current standard of care is to continue administering the drug indefinitely until disease progression. This continuous treatment comes with clinical as well as financial toxicity, which could be especially detrimental in older patients. For patients who achieve a CR after initial zanubrutinib plus rituximab therapy, it may be safe and equally effective to stop treatment and restart zanubrutinib upon disease progression rather than continuing indefinitely in previously untreated older adult patients with MCL.

研究概览

详细说明

PRIMARY OBJECTIVE:

I. To compare time to first progression or death (progression free survival [PFS]1) with continuous treatment (Arm A) and time to second progression or death (PFS2) with intermittent treatment that is restarted at first progression (Arm B).

KEY SECONDARY OBJECTIVE:

I. To compare overall survival between patients who achieve a complete remission (CR) with induction therapy subsequently treated with continuous treatment versus (vs.) intermittent treatment as part of maintenance therapy.

SECONDARY OBJECTIVES:

I. To determine overall response rate (ORR) and CR rate to induction therapy with zanubrutinib and rituximab in previously untreated MCL.

II. To determine adverse events during induction and post-induction in each study arm (Arm A and B) by Common Terminology Criteria for Adverse Events (CTCAE) 5.0.

III. To determine PFS1, event free survival (EFS) and overall survival (OS) in each study arm (A and B).

IV. To determine the overall response rate (ORR) and complete response rate (CR) after restarting zanubrutinib, following the first progression, in the intermittent treatment arm (Arm B).

V. To compare burden of symptomatic adverse events (AEs) as assessed by Patient-Reported Outcome Common Terminology Criteria for Adverse Events (PRO-CTCAE) between patients randomized to Arm A versus Arm B.

QUALITY OF LIFE PRIMARY OBJECTIVE:

I. To compare health-related quality of life (QOL) at 12 months post-randomization as assessed by the Functional Assessment of Cancer Therapy (FACT) Lymphoma Symptom Index-18 (FLYMSI-18) total score between patients randomized to Arm A versus Arm B.

QUALITY OF LIFE SECONDARY OBJECTIVES:

I. To compare health-related QOL at other time points as assessed by the FLYMSI-18 total score between patients randomized to Arm A versus Arm B.

II. To compare burden of symptomatic AEs as assessed by PRO-CTCAE between patients randomized to continuous (Arm A) versus intermittent (Arm B) zanubrutinib treatment.

QUALITY OF LIFE EXPLORATORY OBJECTIVES:

I. To compare the geriatric functional and cognitive PRO as assessed by Elderly Functional Index (ELFI) and Neurology (Neuro) QOL in Arm A versus Arm B.

II. To compare cognitive function at various time points as assessed by the Neuro-QOL between patients randomized to continuous (Arm A) versus intermittent (Arm B) zanubrutinib treatment.

EXPLORATORY OBJECTIVES:

I. To evaluate the completion rate of a lymphoma-specific patient assessment of life survey (PALS) with patient directed questions on life, health, and social determinants of health (SDH) and assess the impact of the survey collected data on outcomes for all enrolled patients (study arms A and B).

II. To evaluate minimal residual disease (MRD) in those patients who achieve a CR after induction therapy (arms A and B) and how detectable MRD status changes after continued therapy vs. discontinuation of therapy (i.e. arms A vs. B).

OUTLINE:

INDUCTION THERAPY: Patients receive zanubrutinib orally (PO) twice daily (BID) on days 1-28 of each cycle and rituximab intravenously (IV) on day 1 of each cycle. Treatment repeats every 28 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity. . Patients undergo bone marrow biopsy and fluciclovine F18 (FDG) positron emission tomography (PET)/ computed tomography (CT) or CT throughout the trial. Patients may also undergo esophagogastroduodenoscopy (EGD) and/or colonoscopy on study as clinically indicated. Patients may optionally undergo blood sample collection throughout the trial.

MAINTENANCE THERAPY: Patients achieving a CR after induction therapy are randomized to 1 of 2 arms.

ARM A: Patients receive zanubrutinib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days until first disease progression on study. Patients undergo CT or magnetic resonance imaging (MRI) or FDG PET/CT throughout the trial. Patients may optionally undergo blood sample collection throughout the trial.

ARM B: Patients undergo observation until first disease progression and then receive zanubrutinib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days until second disease progression on study. Patients undergo CT or MRI or FDG PET/CT throughout the trial. Patients may optionally undergo blood sample collection throughout the trial and may undergo bone marrow biopsy on study.

After completion of study treatment, patients are followed within 30 days and every 6 months for 10 years.

研究类型

介入性

注册 (估计的)

421

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Arkansas
      • Little Rock、Arkansas、美国、72205
        • 招聘中
        • University of Arkansas for Medical Sciences
        • 接触:
          • Site Public Contact
          • 电话号码:501-686-8274
        • 首席研究员:
          • Cesar Gentille
    • California
      • Beverly Hills、California、美国、90211
      • Duarte、California、美国、91010
        • 主动,不招人
        • City of Hope Comprehensive Cancer Center
      • Irvine、California、美国、92618
        • 主动,不招人
        • City of Hope at Irvine Lennar
      • Los Angeles、California、美国、90048
        • 招聘中
        • Cedars-Sinai Medical Center
        • 首席研究员:
          • Justin M. Darrah
        • 接触:
    • Connecticut
      • Derby、Connecticut、美国、06418
        • 招聘中
        • Smilow Cancer Hospital-Derby Care Center
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Fairfield、Connecticut、美国、06824
        • 招聘中
        • Smilow Cancer Hospital Care Center-Fairfield
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Glastonbury、Connecticut、美国、06033
        • 招聘中
        • Smilow Cancer Hospital Care Center at Glastonbury
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Greenwich、Connecticut、美国、06830
        • 招聘中
        • Smilow Cancer Hospital Care Center at Greenwich
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Guilford、Connecticut、美国、06437
        • 招聘中
        • Smilow Cancer Hospital Care Center - Guilford
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Hartford、Connecticut、美国、06105
        • 招聘中
        • Smilow Cancer Hospital Care Center at Saint Francis
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • New Haven、Connecticut、美国、06520
        • 招聘中
        • Yale University
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • North Haven、Connecticut、美国、06473
        • 招聘中
        • Yale-New Haven Hospital North Haven Medical Center
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Stamford、Connecticut、美国、06902
        • 招聘中
        • Smilow Cancer Hospital Care Center at Long Ridge
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Torrington、Connecticut、美国、06790
        • 招聘中
        • Smilow Cancer Hospital-Torrington Care Center
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Trumbull、Connecticut、美国、06611
        • 招聘中
        • Smilow Cancer Hospital Care Center-Trumbull
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Waterbury、Connecticut、美国、06708
        • 招聘中
        • Smilow Cancer Hospital-Waterbury Care Center
        • 首席研究员:
          • Shalin Kothari
        • 接触:
      • Waterford、Connecticut、美国、06385
        • 招聘中
        • Smilow Cancer Hospital Care Center - Waterford
        • 首席研究员:
          • Shalin Kothari
        • 接触:
    • Delaware
      • Newark、Delaware、美国、19713
        • 招聘中
        • Helen F Graham Cancer Center
        • 首席研究员:
          • Gregory A. Masters
        • 接触:
      • Newark、Delaware、美国、19713
        • 招聘中
        • Medical Oncology Hematology Consultants PA
        • 首席研究员:
          • Gregory A. Masters
        • 接触:
    • Georgia
      • Albany、Georgia、美国、31701
        • 招聘中
        • Phoebe Putney Memorial Hospital
        • 首席研究员:
          • Locke J. Bryan
        • 接触:
      • Atlanta、Georgia、美国、30322
        • 招聘中
        • Emory University Hospital/Winship Cancer Institute
        • 接触:
          • Site Public Contact
          • 电话号码:404-778-1868
        • 首席研究员:
          • Jonathon B. Cohen
      • Atlanta、Georgia、美国、30303
        • 招聘中
        • Grady Health System
        • 接触:
          • Site Public Contact
          • 电话号码:404-778-1868
        • 首席研究员:
          • Jonathon B. Cohen
      • Atlanta、Georgia、美国、30308
        • 招聘中
        • Emory University Hospital Midtown
        • 接触:
          • Site Public Contact
          • 电话号码:888-946-7447
        • 首席研究员:
          • Jonathon B. Cohen
      • Atlanta、Georgia、美国、30342
        • 招聘中
        • Emory Saint Joseph's Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:404-851-7115
        • 首席研究员:
          • Jonathon B. Cohen
      • Augusta、Georgia、美国、30912
        • 招聘中
        • Augusta University Medical Center
        • 首席研究员:
          • Locke J. Bryan
        • 接触:
      • Johns Creek、Georgia、美国、30097
        • 招聘中
        • Emory Johns Creek Hospital
        • 首席研究员:
          • Jonathon B. Cohen
        • 接触:
    • Idaho
      • Boise、Idaho、美国、83712
        • 招聘中
        • Saint Luke's Cancer Institute - Boise
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Boise、Idaho、美国、83706
        • 招聘中
        • Saint Alphonsus Cancer Care Center-Boise
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Caldwell、Idaho、美国、83605
        • 招聘中
        • Saint Alphonsus Cancer Care Center-Caldwell
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Coeur d'Alene、Idaho、美国、83814
        • 招聘中
        • Kootenai Health - Coeur d'Alene
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Fruitland、Idaho、美国、83619
        • 招聘中
        • Saint Luke's Cancer Institute - Fruitland
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Meridian、Idaho、美国、83642
        • 招聘中
        • Saint Luke's Cancer Institute - Meridian
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Nampa、Idaho、美国、83687
        • 招聘中
        • Saint Luke's Cancer Institute - Nampa
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Nampa、Idaho、美国、83687
        • 招聘中
        • Saint Alphonsus Cancer Care Center-Nampa
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Post Falls、Idaho、美国、83854
        • 招聘中
        • Kootenai Clinic Cancer Services - Post Falls
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Sandpoint、Idaho、美国、83864
        • 招聘中
        • Kootenai Clinic Cancer Services - Sandpoint
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
    • Illinois
      • Bloomington、Illinois、美国、61704
        • 招聘中
        • Illinois CancerCare-Bloomington
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Canton、Illinois、美国、61520
        • 招聘中
        • Illinois CancerCare-Canton
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Carthage、Illinois、美国、62321
        • 招聘中
        • Illinois CancerCare-Carthage
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Chicago、Illinois、美国、60612
        • 招聘中
        • University of Illinois
        • 接触:
          • Site Public Contact
          • 电话号码:312-355-3046
        • 首席研究员:
          • Carlos Galvez
      • Chicago、Illinois、美国、60606
        • 招聘中
        • Alliance for Clinical Trials in Oncology
        • 首席研究员:
          • Anne W. Beaven
        • 接触:
      • Danville、Illinois、美国、61832
        • 招聘中
        • Carle at The Riverfront
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
        • 接触:
      • Decatur、Illinois、美国、62526
        • 招聘中
        • Cancer Care Specialists of Illinois - Decatur
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Decatur、Illinois、美国、62526
        • 招聘中
        • Decatur Memorial Hospital
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Dixon、Illinois、美国、61021
        • 招聘中
        • Illinois CancerCare-Dixon
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:815-285-7800
      • Effingham、Illinois、美国、62401
        • 招聘中
        • Carle Physician Group-Effingham
        • 接触:
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Effingham、Illinois、美国、62401
        • 招聘中
        • Crossroads Cancer Center
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Eureka、Illinois、美国、61530
        • 招聘中
        • Illinois CancerCare-Eureka
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Evanston、Illinois、美国、60201
        • 招聘中
        • NorthShore University HealthSystem-Evanston Hospital
        • 首席研究员:
          • Amy Y. Wang
        • 接触:
          • Site Public Contact
          • 电话号码:847-570-2109
      • Galesburg、Illinois、美国、61401
        • 招聘中
        • Illinois CancerCare-Galesburg
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Glenview、Illinois、美国、60026
        • 招聘中
        • NorthShore University HealthSystem-Glenbrook Hospital
        • 首席研究员:
          • Amy Y. Wang
        • 接触:
          • Site Public Contact
          • 电话号码:847-570-2109
      • Highland Park、Illinois、美国、60035
        • 招聘中
        • NorthShore University HealthSystem-Highland Park Hospital
        • 首席研究员:
          • Amy Y. Wang
        • 接触:
          • Site Public Contact
          • 电话号码:847-570-2109
      • Kewanee、Illinois、美国、61443
        • 招聘中
        • Illinois CancerCare-Kewanee Clinic
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Macomb、Illinois、美国、61455
        • 招聘中
        • Illinois CancerCare-Macomb
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Mattoon、Illinois、美国、61938
        • 招聘中
        • Carle Physician Group-Mattoon/Charleston
        • 接触:
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Mount Vernon、Illinois、美国、62864
        • 招聘中
        • SSM Health Good Samaritan
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
      • O'Fallon、Illinois、美国、62269
        • 招聘中
        • Cancer Care Center of O'Fallon
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Ottawa、Illinois、美国、61350
        • 招聘中
        • Illinois CancerCare-Ottawa Clinic
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Pekin、Illinois、美国、61554
        • 招聘中
        • Illinois CancerCare-Pekin
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Peoria、Illinois、美国、61615
        • 招聘中
        • Illinois CancerCare-Peoria
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Peru、Illinois、美国、61354
        • 招聘中
        • Illinois CancerCare-Peru
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Princeton、Illinois、美国、61356
        • 招聘中
        • Illinois CancerCare-Princeton
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
      • Shiloh、Illinois、美国、62269
        • 招聘中
        • Memorial Hospital East
        • 接触:
        • 首席研究员:
          • Brad S. Kahl
      • Springfield、Illinois、美国、62702
        • 招聘中
        • Southern Illinois University School of Medicine
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:217-545-7929
      • Springfield、Illinois、美国、62702
        • 招聘中
        • Springfield Clinic
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:800-444-7541
      • Springfield、Illinois、美国、62781
        • 招聘中
        • Springfield Memorial Hospital
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Urbana、Illinois、美国、61801
        • 招聘中
        • Carle Cancer Center
        • 接触:
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Washington、Illinois、美国、61571
        • 招聘中
        • Illinois CancerCare - Washington
        • 接触:
        • 首席研究员:
          • Bryan A. Faller
    • Indiana
      • Crown Point、Indiana、美国、46307
        • 招聘中
        • Northwest Cancer Center - Crown Point
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
        • 接触:
      • Dyer、Indiana、美国、46311
        • 招聘中
        • Northwest Oncology LLC
        • 接触:
          • Site Public Contact
          • 电话号码:219-924-8178
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Hobart、Indiana、美国、46342
        • 招聘中
        • Northwest Cancer Center - Hobart
        • 接触:
          • Site Public Contact
          • 电话号码:219-947-1795
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Hobart、Indiana、美国、46342
        • 招聘中
        • Saint Mary Medical Center
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
        • 接触:
      • Indianapolis、Indiana、美国、46312
        • 招聘中
        • Saint Catherine Hospital
        • 接触:
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Munster、Indiana、美国、46321
        • 招聘中
        • The Community Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:219-836-3349
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Munster、Indiana、美国、46321
        • 招聘中
        • Women's Diagnostic Center - Munster
        • 接触:
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
      • Valparaiso、Indiana、美国、46383
        • 招聘中
        • Northwest Cancer Center - Valparaiso
        • 首席研究员:
          • Maria T. Grosse-Perdekamp
        • 接触:
    • Iowa
      • Ames、Iowa、美国、50010
        • 招聘中
        • Mary Greeley Medical Center
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
          • Site Public Contact
          • 电话号码:515-956-4132
      • Ames、Iowa、美国、50010
        • 招聘中
        • McFarland Clinic - Ames
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
      • Ankeny、Iowa、美国、50023
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Boone、Iowa、美国、50036
        • 暂停
        • McFarland Clinic - Boone
      • Carroll、Iowa、美国、51401
        • 招聘中
        • Saint Anthony Regional Hospital
        • 接触:
        • 首席研究员:
          • Seema Harichand-Herdt
      • Clive、Iowa、美国、50325
        • 招聘中
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50314
        • 招聘中
        • Broadlawns Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:515-282-2200
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50314
        • 招聘中
        • Mercy Medical Center - Des Moines
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Richard L. Deming
      • Des Moines、Iowa、美国、50309
        • 招聘中
        • Iowa Methodist Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-6727
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50309
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50314
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Fort Dodge、Iowa、美国、50501
        • 招聘中
        • McFarland Clinic - Trinity Cancer Center
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
          • Site Public Contact
          • 电话号码:515-956-4132
      • Fort Dodge、Iowa、美国、50501
        • 招聘中
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
        • 首席研究员:
          • Seema Harichand-Herdt
        • 接触:
      • Iowa City、Iowa、美国、52242
        • 招聘中
        • University of Iowa/Holden Comprehensive Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:800-237-1225
        • 首席研究员:
          • Eric Mou
      • Jefferson、Iowa、美国、50129
        • 暂停
        • McFarland Clinic - Jefferson
      • Marshalltown、Iowa、美国、50158
        • 招聘中
        • McFarland Clinic - Marshalltown
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
          • Site Public Contact
          • 电话号码:515-956-4132
      • Waukee、Iowa、美国、50263
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
    • Kansas
      • Hays、Kansas、美国、67601
        • 招聘中
        • HaysMed
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
          • Site Public Contact
          • 电话号码:785-623-5774
      • Kansas City、Kansas、美国、66160
        • 招聘中
        • University of Kansas Cancer Center
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Lawrence、Kansas、美国、66044
        • 招聘中
        • Lawrence Memorial Hospital
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Leavenworth、Kansas、美国、66048
        • 暂停
        • Veteran Administration Eastern Kansas Healthcare
      • Olathe、Kansas、美国、66061
        • 招聘中
        • The University of Kansas Cancer Center - Olathe
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Overland Park、Kansas、美国、66210
        • 招聘中
        • University of Kansas Cancer Center-Overland Park
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Pittsburg、Kansas、美国、66762
        • 招聘中
        • Freeman Physician Group of Pittsburg
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Salina、Kansas、美国、67401
        • 招聘中
        • Salina Regional Health Center
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Topeka、Kansas、美国、66606
        • 招聘中
        • University of Kansas Health System Saint Francis Campus
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
          • Site Public Contact
          • 电话号码:785-295-8000
      • Westwood、Kansas、美国、66205
        • 招聘中
        • University of Kansas Hospital-Westwood Cancer Center
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
    • Kentucky
      • Louisville、Kentucky、美国、40202
        • 招聘中
        • The James Graham Brown Cancer Center at University of Louisville
        • 接触:
          • Site Public Contact
          • 电话号码:502-562-3429
        • 首席研究员:
          • Hassaan Yasin
      • Louisville、Kentucky、美国、40245
        • 招聘中
        • UofL Health Medical Center Northeast
        • 接触:
        • 首席研究员:
          • Hassaan Yasin
    • Michigan
      • Ann Arbor、Michigan、美国、48106
        • 招聘中
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Bay City、Michigan、美国、48706
        • 招聘中
        • McLaren Cancer Institute-Bay City
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Brighton、Michigan、美国、48114
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Brighton、Michigan、美国、48114
        • 招聘中
        • Trinity Health Medical Center - Brighton
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Canton、Michigan、美国、48188
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Canton、Michigan、美国、48188
        • 招聘中
        • Trinity Health Medical Center - Canton
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Chelsea、Michigan、美国、48118
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Chelsea、Michigan、美国、48118
      • Clarkston、Michigan、美国、48346
        • 招聘中
        • McLaren Cancer Institute-Clarkston
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Detroit、Michigan、美国、48201
        • 招聘中
        • Wayne State University/Karmanos Cancer Institute
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Farmington Hills、Michigan、美国、48334
        • 招聘中
        • Weisberg Cancer Treatment Center
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Farmington Hills、Michigan、美国、48336
        • 招聘中
        • Corewell Health Farmington Hills Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • Flint、Michigan、美国、48503
        • 招聘中
        • Genesys Hurley Cancer Institute
        • 首席研究员:
          • Christopher M. Reynolds
        • 接触:
      • Flint、Michigan、美国、48503
        • 招聘中
        • Hurley Medical Center
        • 首席研究员:
          • Christopher M. Reynolds
        • 接触:
      • Flint、Michigan、美国、48532
        • 招聘中
        • McLaren Cancer Institute-Flint
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Flint、Michigan、美国、48503
        • 暂停
        • Genesee Hematology Oncology PC
      • Flint、Michigan、美国、48503
        • 招聘中
        • Cancer Hematology Centers - Flint
        • 首席研究员:
          • Christopher M. Reynolds
        • 接触:
      • Lansing、Michigan、美国、48912
        • 招聘中
        • University of Michigan Health - Sparrow Lansing
        • 首席研究员:
          • Christopher M. Reynolds
        • 接触:
      • Lapeer、Michigan、美国、48446
        • 招聘中
        • McLaren Cancer Institute-Lapeer Region
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Livonia、Michigan、美国、48154
        • 招聘中
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Macomb、Michigan、美国、48044
        • 招聘中
        • Henry Ford Saint John Hospital - Macomb Medical
        • 首席研究员:
          • Christopher M. Reynolds
        • 接触:
      • Mount Pleasant、Michigan、美国、48858
        • 招聘中
        • McLaren Cancer Institute-Central Michigan
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Petoskey、Michigan、美国、49770
        • 招聘中
        • McLaren Cancer Institute-Northern Michigan
        • 首席研究员:
          • Dipenkumar Modi
        • 接触:
      • Pontiac、Michigan、美国、48341
        • 招聘中
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Royal Oak、Michigan、美国、48073
        • 招聘中
        • Corewell Health William Beaumont University Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • Saginaw、Michigan、美国、48604
        • 暂停
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw、Michigan、美国、48601
        • 招聘中
        • MyMichigan Medical Center Saginaw
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Tawas City、Michigan、美国、48764
      • Troy、Michigan、美国、48085
        • 招聘中
        • Corewell Health Beaumont Troy Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • West Branch、Michigan、美国、48661
        • 暂停
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Ypsilanti、Michigan、美国、48106
      • Ypsilanti、Michigan、美国、48197
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
    • Minnesota
      • Bemidji、Minnesota、美国、56601
      • Brainerd、Minnesota、美国、56401
        • 招聘中
        • Essentia Health Saint Joseph's Medical Center
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Coon Rapids、Minnesota、美国、55433
        • 招聘中
        • Mercy Hospital
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Deer River、Minnesota、美国、56636
        • 招聘中
        • Essentia Health - Deer River Clinic
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Duluth、Minnesota、美国、55805
        • 招聘中
        • Essentia Health Cancer Center
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Edina、Minnesota、美国、55435
        • 招聘中
        • Minnesota Oncology - Edina
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Hibbing、Minnesota、美国、55746
        • 招聘中
        • Essentia Health Hibbing Clinic
        • 首席研究员:
          • Bret E. Friday
        • 接触:
          • Site Public Contact
          • 电话号码:218-786-3308
      • Maplewood、Minnesota、美国、55109
        • 招聘中
        • Saint John's Hospital - Healtheast
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Minneapolis、Minnesota、美国、55407
        • 招聘中
        • Abbott-Northwestern Hospital
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Minneapolis、Minnesota、美国、55415
        • 招聘中
        • Hennepin County Medical Center
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Saint Cloud、Minnesota、美国、56303
        • 招聘中
        • Coborn Cancer Center at Saint Cloud Hospital
        • 接触:
        • 首席研究员:
          • Donald J. Jurgens
      • Saint Louis Park、Minnesota、美国、55416
        • 招聘中
        • Park Nicollet Clinic - Saint Louis Park
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Saint Paul、Minnesota、美国、55101
        • 招聘中
        • Regions Hospital
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Saint Paul、Minnesota、美国、55102
        • 招聘中
        • United Hospital
        • 接触:
        • 首席研究员:
          • Yan Ji
      • Sandstone、Minnesota、美国、55072
        • 招聘中
        • Essentia Health Sandstone
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Virginia、Minnesota、美国、55792
        • 招聘中
        • Essentia Health Virginia Clinic
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Woodbury、Minnesota、美国、55125
        • 招聘中
        • Minnesota Oncology Hematology PA-Woodbury
        • 接触:
        • 首席研究员:
          • Yan Ji
    • Missouri
      • Cape Girardeau、Missouri、美国、63703
        • 招聘中
        • Saint Francis Medical Center
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:573-334-2230
          • 邮箱:sfmc@sfmc.net
      • Chesterfield、Missouri、美国、63017
        • 招聘中
        • Saint Luke's Hospital
        • 首席研究员:
          • Mark J. Fesler
        • 接触:
          • Site Public Contact
          • 电话号码:314-205-6936
      • City of Saint Peters、Missouri、美国、63376
        • 招聘中
        • Siteman Cancer Center at Saint Peters Hospital
        • 接触:
        • 首席研究员:
          • Brad S. Kahl
      • Creve Coeur、Missouri、美国、63141
        • 招聘中
        • Siteman Cancer Center at West County Hospital
        • 接触:
        • 首席研究员:
          • Brad S. Kahl
      • Kansas City、Missouri、美国、64154
        • 招聘中
        • University of Kansas Cancer Center - North
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • Kansas City、Missouri、美国、64128
        • 招聘中
        • Kansas City Veterans Affairs Medical Center
        • 首席研究员:
          • Suman Kambhampati
        • 接触:
          • Site Public Contact
          • 电话号码:800-525-1483
      • Kansas City、Missouri、美国、64108
        • 招聘中
        • University Health Truman Medical Center
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
          • Site Public Contact
          • 电话号码:816-404-4375
      • Kansas City、Missouri、美国、64116
        • 招聘中
        • University of Kansas Cancer Center - Briarcliff
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
          • Site Public Contact
          • 电话号码:913-588-3671
      • Lee's Summit、Missouri、美国、64064
        • 招聘中
        • University of Kansas Cancer Center - Lee's Summit
        • 首席研究员:
          • Marc S. Hoffmann
        • 接触:
      • North Kansas City、Missouri、美国、64116
        • 暂停
        • University of Kansas Cancer Center at North Kansas City Hospital
      • Springfield、Missouri、美国、65804
        • 招聘中
        • Mercy Hospital Springfield
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
          • Site Public Contact
          • 电话号码:417-269-4520
      • Springfield、Missouri、美国、65807
        • 招聘中
        • CoxHealth South Hospital
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
          • Site Public Contact
          • 电话号码:417-269-4520
      • St Louis、Missouri、美国、63110
        • 招聘中
        • Washington University School of Medicine
        • 接触:
        • 首席研究员:
          • Brad S. Kahl
      • St Louis、Missouri、美国、63128
        • 招聘中
        • Mercy Hospital South
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
      • St Louis、Missouri、美国、63129
        • 招聘中
        • Siteman Cancer Center-South County
        • 接触:
        • 首席研究员:
          • Brad S. Kahl
      • St Louis、Missouri、美国、63136
        • 招聘中
        • Siteman Cancer Center at Christian Hospital
        • 接触:
        • 首席研究员:
          • Brad S. Kahl
    • Montana
      • Anaconda、Montana、美国、59711
        • 招聘中
        • Community Hospital of Anaconda
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Billings、Montana、美国、59101
        • 招聘中
        • Billings Clinic Cancer Center
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Bozeman、Montana、美国、59715
        • 招聘中
        • Bozeman Health Deaconess Hospital
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Great Falls、Montana、美国、59405
        • 招聘中
        • Benefis Sletten Cancer Institute
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Kalispell、Montana、美国、59901
        • 招聘中
        • Logan Health Medical Center
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Missoula、Montana、美国、59804
        • 招聘中
        • Community Medical Center
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
    • Nebraska
      • Bellevue、Nebraska、美国、68123
        • 招聘中
        • Nebraska Medicine-Bellevue
        • 首席研究员:
          • Julie M. Vose
        • 接触:
      • Kearney、Nebraska、美国、68845
        • 招聘中
        • Fred and Pamela Buffett Cancer Center - Kearney
        • 首席研究员:
          • Julie M. Vose
        • 接触:
      • Omaha、Nebraska、美国、68198
        • 招聘中
        • University of Nebraska Medical Center
        • 首席研究员:
          • Julie M. Vose
        • 接触:
      • Omaha、Nebraska、美国、68118
        • 招聘中
        • Nebraska Medicine-Village Pointe
        • 首席研究员:
          • Julie M. Vose
        • 接触:
          • Site Public Contact
          • 电话号码:402-559-5600
    • New Hampshire
      • Lebanon、New Hampshire、美国、03756
        • 招聘中
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
        • 接触:
        • 首席研究员:
          • Charles Gaulin
    • New York
      • Buffalo、New York、美国、14263
        • 招聘中
        • Roswell Park Cancer Institute
        • 接触:
        • 首席研究员:
          • Chelsea Peterson
      • Camillus、New York、美国、13031
        • 招聘中
        • Hematology Oncology Associates of CNY at Camillus
        • 接触:
          • Site Public Contact
          • 电话号码:315-472-7504
        • 首席研究员:
          • Steven M. Duffy
      • East Syracuse、New York、美国、13057
        • 招聘中
        • Hematology Oncology Associates of Central New York-East Syracuse
        • 接触:
          • Site Public Contact
          • 电话号码:315-472-7504
        • 首席研究员:
          • Steven M. Duffy
      • Mineola、New York、美国、11501
        • 招聘中
        • NYU Langone Hospital - Long Island
        • 首席研究员:
          • Peter Martin
        • 接触:
      • New York、New York、美国、10016
        • 招聘中
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
        • 首席研究员:
          • Peter Martin
        • 接触:
      • New York、New York、美国、10065
        • 招聘中
        • NYP/Weill Cornell Medical Center
        • 首席研究员:
          • Jia Ruan
        • 接触:
          • Site Public Contact
          • 电话号码:212-746-1848
      • Rochester、New York、美国、14642
        • 招聘中
        • University of Rochester
        • 接触:
          • Site Public Contact
          • 电话号码:585-275-5830
        • 首席研究员:
          • Paul M. Barr
      • Webster、New York、美国、14580
    • North Carolina
      • Chapel Hill、North Carolina、美国、27599
        • 招聘中
        • UNC Lineberger Comprehensive Cancer Center
        • 接触:
        • 首席研究员:
          • Anne W. Beaven
      • Durham、North Carolina、美国、27710
        • 招聘中
        • Duke University Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:888-275-3853
        • 首席研究员:
          • Matthew S. McKinney
    • North Dakota
      • Bismarck、North Dakota、美国、58501
      • Fargo、North Dakota、美国、58122
      • Fargo、North Dakota、美国、58103
        • 招聘中
        • Essentia Health Cancer Center-South University Clinic
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Fargo、North Dakota、美国、58122
    • Ohio
      • Columbus、Ohio、美国、43210
        • 招聘中
        • Ohio State University Comprehensive Cancer Center
        • 接触:
        • 首席研究员:
          • David A. Bond
    • Oklahoma
      • Lawton、Oklahoma、美国、73505
        • 招聘中
        • Cancer Centers of Southwest Oklahoma Research
        • 接触:
          • Site Public Contact
          • 电话号码:877-231-4440
        • 首席研究员:
          • Taha Al-Juhaishi
      • Oklahoma City、Oklahoma、美国、73104
        • 招聘中
        • University of Oklahoma Health Sciences Center
        • 接触:
        • 首席研究员:
          • Taha Al-Juhaishi
      • Tulsa、Oklahoma、美国、74146
        • 招聘中
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
        • 接触:
          • Site Public Contact
          • 电话号码:918-505-3200
        • 首席研究员:
          • Mark B. Jennings
    • Oregon
      • Newberg、Oregon、美国、97132
        • 招聘中
        • Providence Newberg Medical Center
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Ontario、Oregon、美国、97914
        • 招聘中
        • Saint Alphonsus Cancer Care Center-Ontario
        • 接触:
        • 首席研究员:
          • Christopher M. Reynolds
      • Oregon City、Oregon、美国、97045
        • 招聘中
        • Providence Willamette Falls Medical Center
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Portland、Oregon、美国、97213
        • 招聘中
        • Providence Portland Medical Center
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Portland、Oregon、美国、97225
        • 招聘中
        • Providence Saint Vincent Medical Center
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
    • Rhode Island
      • Providence、Rhode Island、美国、02903
        • 招聘中
        • Rhode Island Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:401-444-1488
        • 首席研究员:
          • Adam J. Olszewski
      • Westerly、Rhode Island、美国、02891
        • 招聘中
        • Smilow Cancer Hospital Care Center - Westerly
        • 首席研究员:
          • Shalin Kothari
        • 接触:
    • South Carolina
      • Boiling Springs、South Carolina、美国、29316
        • 招聘中
        • Prisma Health Cancer Institute - Spartanburg
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
      • Charleston、South Carolina、美国、29425
        • 招聘中
        • Medical University of South Carolina
        • 接触:
        • 首席研究员:
          • Katherine Antel
      • Easley、South Carolina、美国、29640
        • 招聘中
        • Prisma Health Cancer Institute - Easley
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
      • Greenville、South Carolina、美国、29605
        • 招聘中
        • Prisma Health Cancer Institute - Faris
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
      • Greenville、South Carolina、美国、29605
        • 招聘中
        • Prisma Health Cancer Institute - Butternut
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
      • Greenville、South Carolina、美国、29615
        • 招聘中
        • Prisma Health Cancer Institute - Eastside
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
      • Greer、South Carolina、美国、29650
        • 招聘中
        • Prisma Health Cancer Institute - Greer
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
      • Seneca、South Carolina、美国、29672
        • 招聘中
        • Prisma Health Cancer Institute - Seneca
        • 首席研究员:
          • Suzanne R. Fanning
        • 接触:
    • South Dakota
      • Sioux Falls、South Dakota、美国、57104
      • Sioux Falls、South Dakota、美国、57117-5134
    • Utah
      • Salt Lake City、Utah、美国、84112
        • 招聘中
        • Huntsman Cancer Institute/University of Utah
        • 接触:
        • 首席研究员:
          • Harsh Shah
    • Vermont
      • Saint Johnsbury、Vermont、美国、05819
        • 招聘中
        • Dartmouth Cancer Center - North
        • 接触:
        • 首席研究员:
          • Charles Gaulin
    • Virginia
      • Richmond、Virginia、美国、23235
        • 招聘中
        • VCU Massey Cancer Center at Stony Point
        • 接触:
        • 首席研究员:
          • Bruce O. Hough
      • Richmond、Virginia、美国、23298
        • 招聘中
        • VCU Massey Comprehensive Cancer Center
        • 首席研究员:
          • Bruce O. Hough
        • 接触:
    • Washington
      • Edmonds、Washington、美国、98026
        • 招聘中
        • Swedish Cancer Institute-Edmonds
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Issaquah、Washington、美国、98029
        • 招聘中
        • Swedish Cancer Institute-Issaquah
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
      • Seattle、Washington、美国、98122
        • 招聘中
        • Swedish Medical Center-First Hill
        • 首席研究员:
          • Alison K. Conlin
        • 接触:
    • Wisconsin
      • Appleton、Wisconsin、美国、54911
        • 招聘中
        • ThedaCare Regional Cancer Center
        • 接触:
        • 首席研究员:
          • Yazhini Vallatharasu
      • Appleton、Wisconsin、美国、54911
        • 招聘中
        • ThedaCare Regional Medical Center - Appleton
        • 接触:
        • 首席研究员:
          • Yazhini Vallatharasu
      • Ashland、Wisconsin、美国、54806
        • 招聘中
        • Duluth Clinic Ashland
        • 接触:
        • 首席研究员:
          • Bret E. Friday
      • Eau Claire、Wisconsin、美国、54701
      • Johnson Creek、Wisconsin、美国、53038
        • 招聘中
        • University of Wisconsin Carbone Cancer Center - Johnson Creek
        • 首席研究员:
          • Priyanka Pophali
        • 接触:
      • La Crosse、Wisconsin、美国、54601
        • 招聘中
        • Gundersen Lutheran Medical Center
        • 接触:
        • 首席研究员:
          • Michael O. Ojelabi
      • Madison、Wisconsin、美国、53792
        • 招聘中
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • 首席研究员:
          • Priyanka Pophali
        • 接触:
      • Madison、Wisconsin、美国、53718
        • 招聘中
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
        • 首席研究员:
          • Priyanka Pophali
        • 接触:
      • Marshfield、Wisconsin、美国、54449
      • Milwaukee、Wisconsin、美国、53226
        • 招聘中
        • Medical College of Wisconsin
        • 接触:
          • Site Public Contact
          • 电话号码:414-805-3666
        • 首席研究员:
          • Mehdi Hamadani
      • Minocqua、Wisconsin、美国、54548
      • Mukwonago、Wisconsin、美国、53149
        • 招聘中
        • ProHealth D N Greenwald Center
        • 接触:
        • 首席研究员:
          • Timothy R. Wassenaar
      • New Berlin、Wisconsin、美国、53151
        • 招聘中
        • Froedtert and MCW Moorland Reserve Health Center
        • 接触:
          • Site Public Contact
          • 电话号码:414-805-0505
        • 首席研究员:
          • Mehdi Hamadani
      • Oconomowoc、Wisconsin、美国、53066
        • 招聘中
        • ProHealth Oconomowoc Memorial Hospital
        • 首席研究员:
          • Timothy R. Wassenaar
        • 接触:
          • Site Public Contact
          • 电话号码:262-928-7878
      • Rice Lake、Wisconsin、美国、54868
      • Stevens Point、Wisconsin、美国、54482
      • Waukesha、Wisconsin、美国、53188
        • 招聘中
        • UW Cancer Center at ProHealth Care
        • 首席研究员:
          • Timothy R. Wassenaar
        • 接触:
      • Weston、Wisconsin、美国、54476

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

60年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • • Histologically confirmed mantle cell lymphoma with cyclin D1 (BCL1) expression by immunohistochemical stains and/or evidence of CCND1 rearrangement or t(11;14)(q13;q32) as confirmed by the enrolling center (such as by fluorescence in situ hybridization [FISH], polymerase chain reaction [PCR]/sequencing, karyotype). Patients with cyclin D1 and/or t(11;14) negative mantle cell lymphoma with an expression profile suggesting a diagnosis of mantle cell lymphoma [MCL] such as SOX11 expression are also eligible

    • Any stage allowed (stage I-IV)

      • Patient must have at least one objective measurable disease parameter by PET or CT. Measurable disease in the liver is required if the liver is the only site of lymphoma OR bone marrow involvement by MCL
      • Steroids for management of mantle cell lymphoma are allowed up to a dose of prednisone 100mg/day (or equivalent) for up to 7 days prior to registration
      • No prior systemic treatment for mantle cell lymphoma
      • No prior radiation treatment for stage I MCL
      • No prior exposure to a BTK inhibitor or anti-CD20 monoclonal antibody
      • No prior stem cell transplant
      • Age >= 70 years OR age >= 60 to < 70 years with comorbidities precluding autologous stem cell transplantation (autoSCT) including at least one of the following: a) cardiac ejection fraction (EF) <= 45%, b) diffusing capacity for carbon monoxide <= 60% predicted; c) creatinine clearance < 70 but >= 30ml/minute (min); d) Eastern Cooperative Oncology Group (ECOG) performance status of 2, which poses an unacceptable risk of toxicity for high-dose therapy and stem cell transplantation; or e) Cumulative Illness Rating Scales (CIRS) total score > 6
      • ECOG Performance Status 0-2
      • Absolute neutrophil count (ANC) >= 750/mm^3 (without growth factor support within 7 days)
      • Platelet count >= 75,000/mm^3 (or >= 50,000/mm^3 if thrombocytopenia is due to lymphoma) without growth factor support or transfusion within 7 days
      • Creatinine clearance >= 30 mL/ min determined by either: a) Estimation using the Cockcroft-Gault equation or b) Measurement by nuclear medicine scan or 24 hour urine collection
      • Total bilirubin =< 1.5 x upper limit of normal (ULN) (unless documented Gilbert's syndrome)
      • Aspartate transferase (AST) / alanine transaminase (ALT) =< 3 x ULN
      • Patients should not be considered candidates for stem cell transplant or must have declined a stem cell transplant strategy
      • No clinically significant cardiovascular disease including the following
    • Unstable angina within 3 months before registration

    • New York Heart Association class III or IV congestive heart failure

    • History of clinically significant arrhythmias (eg, sustained ventricular tachycardia, ventricular fibrillation, torsades de pointes)

    • Known QT correction formula (QTcF) > 480 msecs based on Fredericia's formula (unless pacemaker in place)

    • History of Mobitz II second-degree or third-degree heart block without a permanent pacemaker in place

      • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial
      • No active Hepatitis B or Hepatitis C infection. Patients with prior hepatitis B virus (HBV) exposure (positive HBV core antibody and/or surface antigen) are eligible if they have no detectable viral load, and are taking appropriate prophylactic antiviral therapy to prevent reactivation. Patients with history of hepatitis C virus (HCV) are eligible if they have an undetectable HCV viral load
      • Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
      • No history of severe bleeding disorder such as hemophilia A, hemophilia B, von Willebrand disease, or history of spontaneous bleeding requiring blood transfusion or other medical intervention
      • No history of stroke or intracranial hemorrhage within 6 months prior to registration
      • No disease significantly affecting gastrointestinal function such as malabsorption syndrome, resection of the stomach or small bowel, bariatric surgery procedures, symptomatic inflammatory bowel disease, or partial or complete bowel obstruction. Patient must be able to swallow pills
      • Potential trial participants should have recovered from major surgery
      • No vaccination with a live vaccine within 35 days prior to registration
      • No hypersensitivity to zanubrutinib or rituximab or any of the other ingredients of the study drugs
      • Patients on strong CYP3A4 inhibitors must discontinue the drug for 14 days prior to registration on the study.
      • Patients on strong CYP3A4 inducers must discontinue the drug 14 days prior to registration.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Induction therapy (Zanubrutinib, rituximab)

Patients receive zanubrutinib PO and rituximab IV on study. Patients undergo bone marrow biopsy and FDG PET/CT or CT throughout the trial. Patients may also undergo EDG and/or colonoscopy on study as clinically indicated. Patients may optionally undergo blood sample collection throughout the trial.

Undergo blood sample collection

Given IV

Undergo CT

其他名称:
  • 电脑扫描
  • CT扫描

Undergo MRI

其他名称:
  • 核磁共振

Ancillary studies

Undergo PET

其他名称:
  • 宠物

Undergo colonoscopy

Undergo observation

Undergo EGD

其他名称:
  • EGD

Given PO

undergo bone marrow biopsy

Given IV

实验性的:Arm A (Zanubrutinib)

Patients receive zanubrutinib PO until first disease progression on study. Patients undergo CT or MRI or FDG PET/CT throughout the trial. Patients may optionally undergo blood sample collection throughout the trial.

Undergo blood sample collection

Undergo CT

其他名称:
  • 电脑扫描
  • CT扫描

Undergo MRI

其他名称:
  • 核磁共振

Ancillary studies

Undergo PET

其他名称:
  • 宠物

Undergo colonoscopy

Undergo observation

Undergo EGD

其他名称:
  • EGD

Given PO

undergo bone marrow biopsy

Given IV

有源比较器:ARM B (Observation)

Patients undergo observation until first disease progression and then receive zanubrutinib PO until second disease progression on study. Patients undergo CT or MRI or FDG PET/CT throughout the trial. Patients may optionally undergo blood sample collection throughout the trial.

Undergo blood sample collection

Undergo CT

其他名称:
  • 电脑扫描
  • CT扫描

Undergo MRI

其他名称:
  • 核磁共振

Ancillary studies

Undergo PET

其他名称:
  • 宠物

Undergo colonoscopy

Undergo observation

Undergo EGD

其他名称:
  • EGD

Given PO

undergo bone marrow biopsy

Given IV

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Progression-free survival (PFS) 1 (Arm A)
大体时间:Time from randomization until the earlier of first progression or death from any cause, assessed up to 10 years

Hazard ratios on the treatment effect will be estimated using a stratified cox proportional hazards model, stratified on age and mantle cell lymphoma (MCL) International Prognostic Index (IPI) score. The primary analysis for non-inferiority will be based on an intent-to-treat (ITT) analysis and will include all randomized patients in the analyses, regardless of eligibility or treatment status. Sensitivity analyses will also be done in an ancillary manner to evaluate and compare our endpoints using a modified ITT approach, and exclude from the analysis those classified as ineligible as well as those who withdraw right after randomization prior to any treatment/observation monitoring.

Time from randomization until the earlier of first progression or death from any cause, assessed up to 10 years
Progression-free survival (PFS) 2 (Arm B)
大体时间:Time from randomization until the earlier of second progression or death from any cause, assessed up to 10 years

Hazard ratios on the treatment effect will be estimated using a stratified cox proportional hazards model, stratified on age and MCL IPI score. The primary analysis for non-inferiority will be based on an ITT analysis and will include all randomized patients in the analyses, regardless of eligibility or treatment status. Sensitivity analyses will also be done in an ancillary manner to evaluate and compare our endpoints using a modified ITT approach, and exclude from the analysis those classified as ineligible as well as those who withdraw right after randomization prior to any treatment/observation monitoring.

Time from randomization until the earlier of second progression or death from any cause, assessed up to 10 years

次要结果测量

结果测量
措施说明
大体时间
Overall survival (OS) (Arms A and B)
大体时间:Time from randomization until death from any cause, assessed up to 10 years

Kaplan-Meier methodology will be used to estimate the distributions of OS by treatment arm and log-rank test statistics will be used to compare these distributions between the two treatment arms. Cox Proportional Hazards models may be used to further evaluate covariates of interest with OS, including assessment of treatment effects when adjusting for other known risk factors in the model.

Time from randomization until death from any cause, assessed up to 10 years
Incidence of adverse events
大体时间:Up to 10 years

Will be evaluated and captured using the CTCAE 5.0, where the type and severity grade of each adverse event will be collected and tabulated within each of the treatment arms. Perceived attribution to study treatment will also be captured.

The analysis population for this secondary endpoint will include all patients who are registered and randomized on the study and receive at least one dose of study treatment. Adverse events will be monitored continuously throughout the course of the study as well as analyzed at the time of the final primary endpoint analysis.

Summary statistics and frequency tables will be used to describe the distributions of adverse events. Rates of adverse events occurring in compared across the treatment arms with chi-squared tests Tolerability will also be evaluated, summarizing rates of dose delays or modifications, reasons patients end treatment, and time to end of active treatment.

Up to 10 years
Overall response rate (ORR, complete + partial remission)
大体时间:up to 10 years

Will be assessed using Lugano criteria. ORR to induction is defined as the number of patients with complete or partial remission at the end of induction divided by the number of patients who receive at least one dose of the induction regimen. ORR to restart of zanubrutinib is only defined for Arm B, as the number of patients with complete or partial remission after restart of zanubrutinib divided by the number of patients that restart zanubrutinib after first disease progression following randomization. The frequencies and rates of tumor response categories will be summarized by treatment arm for response to induction as well as response to restart of zanubrutinib (Arm B only). ORR to induction and ORR to restart of zanubrutinib (Arm B only) with 95% exact binomial confidence intervals will be calculated by treatment arm. To compare the association of treatment arm and ORR to induction, chi-squared or Fisher's Exact test will be used, whichever is more appropriate at final analysis.

up to 10 years
Complete response rate (CR)
大体时间:Up to 10 years

Will be assessed using Lugano criteria. CR to induction is defined as the number of patients with complete remission at the end of induction divided by the number of eligible patients who receive at least one dose of the induction regimen. CR to restart of zanubrutinib is only defined for Arm B, as the number of patients with complete remission after restart of zanubrutinib divided by the number of eligible patients that restart zanubrutinib after first disease progression following randomization. CR to induction and CR to restart of zanubrutinib (Arm B patients only) with 95% exact binomial confidence intervals will be calculated by treatment arm. To compare the association of treatment arm and CR to induction, chi-squared or Fisher's Exact test will be used, whichever is more appropriate at the time of the final analysis.

Up to 10 years
Event-free survival (EFS) 1
大体时间:Time from randomization (Arms A and B) until the earlier of first progression, start of an alternative MCL therapy, or death from any cause, assessed up to 10 years.

For EFS1, patients without an event will be censored at the last known clinical assessment. Any patient who goes to transplant will be censored at the last known clinical assessment prior to transplant. Kaplan-Meier methodology will be used to estimate the distribution of EFS. Cox Proportional Hazards models may be used to further evaluate covariates of interest with EFS.

Time from randomization (Arms A and B) until the earlier of first progression, start of an alternative MCL therapy, or death from any cause, assessed up to 10 years.
Event-free survival (EFS) 2
大体时间:Time from randomization (Arm B) until the earlier of second progression, start of an alternative MCL therapy, or death from any cause, assessed up to 10 years.

For EFS2, patients without an event will be censored at the last known clinical assessment. Any patient who goes to transplant will be censored at the last known clinical assessment prior to transplant. Kaplan-Meier methodology will be used to estimate the distribution of EFS. Cox Proportional Hazards models may be used to further evaluate covariates of interest with EFS.

Time from randomization (Arm B) until the earlier of second progression, start of an alternative MCL therapy, or death from any cause, assessed up to 10 years.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年10月20日

初级完成 (估计的)

2038年8月31日

研究完成 (估计的)

2038年8月31日

研究注册日期

首次提交

2023年7月26日

首先提交符合 QC 标准的

2023年7月26日

首次发布 (实际的)

2023年8月4日

研究记录更新

最后更新发布 (实际的)

2026年11月3日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅